News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

T2Biosystems Establishes Clinical Advisory Board of Leading Infectious Disease and Critical Care Experts



5/23/2011 7:33:53 AM

T2 Biosystems, Inc., a company developing next-generation diagnostic products to improve clinical care, today announced that a panel of leading infectious disease and critical care experts have joined the company’s newly formed Clinical Advisory Board (CAB). The T2 Biosystems CAB members will help prioritize and support the development of the company’s pipeline of diagnostic products for infectious diseases and acute care conditions, including the lead development application for detection of the fungal infection Candida, using the company’s assay and magnetic biosensor nanotechnology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES